AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
STRIATAL NMDA RECEPTOR-MEDIATED STIMULATION OF CAMP INVOLVES ADENOSINE A(2A) RECEPTOR ACTIVATION AND IS ENHANCED IN PARKINSONISM
Authors: NASH JE BROTCHIE JM
Citation: Je. Nash et Jm. Brotchie, STRIATAL NMDA RECEPTOR-MEDIATED STIMULATION OF CAMP INVOLVES ADENOSINE A(2A) RECEPTOR ACTIVATION AND IS ENHANCED IN PARKINSONISM, European journal of neuroscience, 10, 1998, pp. 6902-6902
MU-OPIOID RECEPTOR-BINDING IN THE BASAL GANGLIA IN RODENT MODELS OF PARKINSONS-DISEASE
Authors: BEGUM S BROTCHIE JM
Citation: S. Begum et Jm. Brotchie, MU-OPIOID RECEPTOR-BINDING IN THE BASAL GANGLIA IN RODENT MODELS OF PARKINSONS-DISEASE, European journal of neuroscience, 10, 1998, pp. 6903-6903
REDUCTION OF L-DOPA-INDUCED DYSKINESIA BY ALPHA(2)-ADRENERGIC RECEPTOR ANTAGONISTS IN THE MPTP-LESIONED MARMOSET MODEL OF PARKINSONS-DISEASE
Authors: HENRY B FOX SH PEGGS D CROSSMAN AR BROTCHIE JM
Citation: B. Henry et al., REDUCTION OF L-DOPA-INDUCED DYSKINESIA BY ALPHA(2)-ADRENERGIC RECEPTOR ANTAGONISTS IN THE MPTP-LESIONED MARMOSET MODEL OF PARKINSONS-DISEASE, European journal of neuroscience, 10, 1998, pp. 6904-6904
INVOLVEMENT OF OPIOID-PEPTIDES IN L-DOPA INDUCED DYSKINESIA IN PARKINSONISM
Authors: OBYRNE MB HENRY B CROSSMAN AR BROTCHIE JM
Citation: Mb. Obyrne et al., INVOLVEMENT OF OPIOID-PEPTIDES IN L-DOPA INDUCED DYSKINESIA IN PARKINSONISM, European journal of neuroscience, 10, 1998, pp. 6905-6905
STRIATAL NR2B NMDA RECEPTOR SUBUNIT EXPRESSION IS ELEVATED FOLLOWING D2, BUT NOT D1, DOPAMINE-RECEPTOR ANTAGONISM IN RAT
Authors: RAVENSCROFT P NASH JE BROTCHIE JM
Citation: P. Ravenscroft et al., STRIATAL NR2B NMDA RECEPTOR SUBUNIT EXPRESSION IS ELEVATED FOLLOWING D2, BUT NOT D1, DOPAMINE-RECEPTOR ANTAGONISM IN RAT, European journal of neuroscience, 10, 1998, pp. 6906-6906
THE CANNABINOID RECEPTOR ANTAGONIST SR141716A REDUCES L-DOPA-INDUCED DYSKINESIA IN THE MPTP-TREATED PRIMATE MODEL OF PARKINSONS-DISEASE
Authors: HILL M FOX S HENRY B PEGGS D CROSSMAN AR BROTCHIE JM
Citation: M. Hill et al., THE CANNABINOID RECEPTOR ANTAGONIST SR141716A REDUCES L-DOPA-INDUCED DYSKINESIA IN THE MPTP-TREATED PRIMATE MODEL OF PARKINSONS-DISEASE, European journal of neuroscience, 10, 1998, pp. 13102-13102
ADJUNCTS TO DOPAMINE REPLACEMENT - A PRAGMATIC APPROACH TO REDUCING THE PROBLEM OF DYSKINESIA IN PARKINSONS-DISEASE
Authors: BROTCHIE JM
Citation: Jm. Brotchie, ADJUNCTS TO DOPAMINE REPLACEMENT - A PRAGMATIC APPROACH TO REDUCING THE PROBLEM OF DYSKINESIA IN PARKINSONS-DISEASE, Movement disorders, 13(6), 1998, pp. 871-876
[H-3]-2-DEOXYGLUCOSE UPTAKE STUDY IN MUTANT DYSTONIC HAMSTERS - ABNORMALITIES IN DISCRETE BRAIN-REGIONS OF THE MOTOR SYSTEM
Authors: RICHTER A BROTCHIE JM CROSSMAN AR LOSCHER W
Citation: A. Richter et al., [H-3]-2-DEOXYGLUCOSE UPTAKE STUDY IN MUTANT DYSTONIC HAMSTERS - ABNORMALITIES IN DISCRETE BRAIN-REGIONS OF THE MOTOR SYSTEM, Movement disorders, 13(4), 1998, pp. 718-725
KAPPA-OPIOID RECEPTOR AGONISTS INCREASE LOCOMOTOR-ACTIVITY IN THE MONOAMINE-DEPLETED RAT MODEL OF PARKINSONISM
Authors: HUGHES NR MCKNIGHT AT WOODRUFF GN HILL MP CROSSMAN AR BROTCHIE JM
Citation: Nr. Hughes et al., KAPPA-OPIOID RECEPTOR AGONISTS INCREASE LOCOMOTOR-ACTIVITY IN THE MONOAMINE-DEPLETED RAT MODEL OF PARKINSONISM, Movement disorders, 13(2), 1998, pp. 228-233
CHARACTERIZATION OF ENHANCED BEHAVIORAL-RESPONSES TO L-DOPA FOLLOWINGREPEATED ADMINISTRATION IN THE 6-HYDROXYDOPAMINE-LESIONED RAT MODEL OF PARKINSONS-DISEASE
Authors: HENRY B CROSSMAN AR BROTCHIE JM
Citation: B. Henry et al., CHARACTERIZATION OF ENHANCED BEHAVIORAL-RESPONSES TO L-DOPA FOLLOWINGREPEATED ADMINISTRATION IN THE 6-HYDROXYDOPAMINE-LESIONED RAT MODEL OF PARKINSONS-DISEASE, Experimental neurology, 151(2), 1998, pp. 334-342
BEHAVIORAL-EFFECTS OF 5-HT2C RECEPTOR ANTAGONISM IN THE SUBSTANTIA-NIGRA ZONA RETICULATA OF THE 6-HYDROXYDOPAMINE-LESIONED RAT MODEL OF PARKINSONS-DISEASE
Authors: FOX SH MOSER B BROTCHIE JM
Citation: Sh. Fox et al., BEHAVIORAL-EFFECTS OF 5-HT2C RECEPTOR ANTAGONISM IN THE SUBSTANTIA-NIGRA ZONA RETICULATA OF THE 6-HYDROXYDOPAMINE-LESIONED RAT MODEL OF PARKINSONS-DISEASE, Experimental neurology, 151(1), 1998, pp. 35-49
TOPOGRAPHICAL ORGANIZATION OF OPIOID PEPTIDE PRECURSOR GENE-EXPRESSION FOLLOWING REPEATED APOMORPHINE TREATMENT IN THE 6-HYDROXYDOPAMINE-LESIONED RAT
Authors: DUTY S HENRY B CROSSMAN AR BROTCHIE JM
Citation: S. Duty et al., TOPOGRAPHICAL ORGANIZATION OF OPIOID PEPTIDE PRECURSOR GENE-EXPRESSION FOLLOWING REPEATED APOMORPHINE TREATMENT IN THE 6-HYDROXYDOPAMINE-LESIONED RAT, Experimental neurology, 150(2), 1998, pp. 223-234
THE CANNABINOID RECEPTOR ANTAGONIST SR141716A REDUCES L-DOPA-INDUCED DYSKINESIA IN THE MPTP-TREATED PRIMATE MODEL OF PARKINSONS-DISEASE
Authors: BROTCHIE JM FOX S HENRY B HILLE C MANEUF CY MCGUIRE S PEGGS D CROSSMAN AR
Citation: Jm. Brotchie et al., THE CANNABINOID RECEPTOR ANTAGONIST SR141716A REDUCES L-DOPA-INDUCED DYSKINESIA IN THE MPTP-TREATED PRIMATE MODEL OF PARKINSONS-DISEASE, British Journal of Pharmacology, 123, 1998, pp. 66-66
ANTI-PARKINSONIAN EFFECT OF NR2B-SELECTIVE NMDA ANTAGONISTS - A STRIATAL MECHANISM OF ACTION
Authors: NASH JE CROSSMAN AR BROTCHIE JM
Citation: Je. Nash et al., ANTI-PARKINSONIAN EFFECT OF NR2B-SELECTIVE NMDA ANTAGONISTS - A STRIATAL MECHANISM OF ACTION, British Journal of Pharmacology, 123, 1998, pp. 67-67
MASTER OF RESEARCH (MRES) IN BIOLOGICAL SCIENCES - THE MANCHESTER EXPERIENCE
Authors: BROTCHIE JM NASH JE BALMENT RJ
Citation: Jm. Brotchie et al., MASTER OF RESEARCH (MRES) IN BIOLOGICAL SCIENCES - THE MANCHESTER EXPERIENCE, British Journal of Pharmacology, 123, 1998, pp. 361-361
NOVEL APPROACHES TO THE SYMPTOMATIC TREATMENT OF PARKINSONIAN SYNDROMES - ALTERNATIVES AND ADJUNCTS TO DOPAMINE-REPLACEMENT
Authors: BROTCHIE JM
Citation: Jm. Brotchie, NOVEL APPROACHES TO THE SYMPTOMATIC TREATMENT OF PARKINSONIAN SYNDROMES - ALTERNATIVES AND ADJUNCTS TO DOPAMINE-REPLACEMENT, Current opinion in neurology, 10(4), 1997, pp. 340-345
MODULATION OF NEUROTRANSMISSION BY CANNABINOIDS IN THE BASAL GANGLIA
Authors: GLASS M BROTCHIE JM MANEUF YP
Citation: M. Glass et al., MODULATION OF NEUROTRANSMISSION BY CANNABINOIDS IN THE BASAL GANGLIA, European journal of neuroscience, 9(2), 1997, pp. 199-203
THE CANNABINOID RECEPTOR AGONIST WIN-55,212-2 REDUCES D-2, BUT NOT D-1, DOPAMINE RECEPTOR-MEDIATED ALLEVIATION OF AKINESIA IN THE RESERPINE-TREATED RAT MODEL OF PARKINSONS-DISEASE
Authors: MANEUF YP CROSSMAN AR BROTCHIE JM
Citation: Yp. Maneuf et al., THE CANNABINOID RECEPTOR AGONIST WIN-55,212-2 REDUCES D-2, BUT NOT D-1, DOPAMINE RECEPTOR-MEDIATED ALLEVIATION OF AKINESIA IN THE RESERPINE-TREATED RAT MODEL OF PARKINSONS-DISEASE, Experimental neurology, 148(1), 1997, pp. 265-270
ENHANCEMENT OF THE BEHAVIORAL-RESPONSE TO APOMORPHINE ADMINISTRATION FOLLOWING REPEATED TREATMENT IN THE 6-HYDROXYDOPAMINE-LESIONED RAT IS TEMPORALLY CORRELATED WITH A RISE IN STRIATAL PREPROENKEPHALIN-B, BUT NOT PREPROENKEPHALIN-A, GENE-EXPRESSION
Authors: DUTY S BROTCHIE JM
Citation: S. Duty et Jm. Brotchie, ENHANCEMENT OF THE BEHAVIORAL-RESPONSE TO APOMORPHINE ADMINISTRATION FOLLOWING REPEATED TREATMENT IN THE 6-HYDROXYDOPAMINE-LESIONED RAT IS TEMPORALLY CORRELATED WITH A RISE IN STRIATAL PREPROENKEPHALIN-B, BUT NOT PREPROENKEPHALIN-A, GENE-EXPRESSION, Experimental neurology, 144(2), 1997, pp. 423-432
PARADOXICAL ACTION OF THE CANNABINOID WIN-55,212-2 IN STIMULATED AND BASAL CYCLIC-AMP ACCUMULATION IN RAT GLOBUS-PALLIDUS SLICES
Authors: MANEUF YP BROTCHIE JM
Citation: Yp. Maneuf et Jm. Brotchie, PARADOXICAL ACTION OF THE CANNABINOID WIN-55,212-2 IN STIMULATED AND BASAL CYCLIC-AMP ACCUMULATION IN RAT GLOBUS-PALLIDUS SLICES, British Journal of Pharmacology, 120(8), 1997, pp. 1397-1398
NEW TREATMENTS FOR MOVEMENT-DISORDERS
Authors: FOX SH BROTCHIE JM
Citation: Sh. Fox et Jm. Brotchie, NEW TREATMENTS FOR MOVEMENT-DISORDERS, Trends in pharmacological sciences, 17(10), 1996, pp. 339-342
POTENTIAL OF OPIOID ANTAGONISTS IN THE TREATMENT OF LEVODOPA-INDUCED DYSKINESIAS IN PARKINSONS-DISEASE
Authors: HENRY B BROTCHIE JM
Citation: B. Henry et Jm. Brotchie, POTENTIAL OF OPIOID ANTAGONISTS IN THE TREATMENT OF LEVODOPA-INDUCED DYSKINESIAS IN PARKINSONS-DISEASE, Drugs & aging, 9(3), 1996, pp. 149-158
IONOTROPIC GLUTAMATE RECEPTORS AND NITRIC-OXIDE SYNTHESIS IN THE RAT STRIATUM
Authors: EAST SJ PARRYJONES A BROTCHIE JM
Citation: Sj. East et al., IONOTROPIC GLUTAMATE RECEPTORS AND NITRIC-OXIDE SYNTHESIS IN THE RAT STRIATUM, NeuroReport, 8(1), 1996, pp. 71-75
MODULATION OF GABAERGIC TRANSMISSION IN THE GLOBUS-PALLIDUS BY THE SYNTHETIC CANNABINOID WIN-55,212-2
Authors: MANEUF YP CROSSMAN AR BROTCHIE JM
Citation: Yp. Maneuf et al., MODULATION OF GABAERGIC TRANSMISSION IN THE GLOBUS-PALLIDUS BY THE SYNTHETIC CANNABINOID WIN-55,212-2, Synapse, 22(4), 1996, pp. 382-385
MODULATION OF GABA TRANSMISSION BY DIAZOXIDE AND CROMAKALIM IN THE GLOBUS-PALLIDUS - IMPLICATIONS FOR THE TREATMENT OF PARKINSONS-DISEASE
Authors: MANEUF YP DUTY S HILLE CJ CROSSMAN AR BROTCHIE JM
Citation: Yp. Maneuf et al., MODULATION OF GABA TRANSMISSION BY DIAZOXIDE AND CROMAKALIM IN THE GLOBUS-PALLIDUS - IMPLICATIONS FOR THE TREATMENT OF PARKINSONS-DISEASE, Experimental neurology, 139(1), 1996, pp. 12-16
Risultati: 1-25 | 26-33